Business Context and Reporting Period
This Form 8-K is filed by Greatbatch, Inc. (not Integer Holdings Corp) for the reporting period of November 14, 2005. The filing discloses a strategic restructuring plan approved by management to reduce costs and improve manufacturing efficiencies.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the approval of exit and disposal activities rather than financial performance metrics.
Material Changes
- Facility Closures: Management approved the closure of the Columbia, MD facility and the Fremont, CA Advanced Research Laboratory.
- Operational Consolidation: Manufacturing operations at Columbia will be consolidated into the Tijuana, Mexico facility.
- Relocation of Functions: Research, development, and engineering (RD&E) functions from both Columbia and Fremont will relocate to the Technology Center in Clarence, New York.
Guidance, Outlook, and Risks
Management's commentary indicates the primary objective is to decrease the cost structure and improve manufacturing efficiencies. The filing notes the issuance of a press release on November 16, 2005, to announce these consolidations. No specific financial guidance, risk factors, or quantified contingencies regarding the costs of these exit activities are detailed in the text of this filing.
Investor Verification Checklist
- Verify the total estimated costs associated with the closure of the Columbia and Fremont facilities.
- Confirm the timeline for the completion of the manufacturing consolidation in Tijuana.
- Review the attached Exhibit 99.1 (Press Release) for additional details on the impact on employee headcount.
- Check subsequent filings for the actual financial impact of these restructuring charges on the next quarterly report.